Medpace Outperforms Q2 Expectations: Analyst Says High Expectations, Softer Margins Will Likely Temper Enthusiasm

By Vandana Singh

Medpace Holdings Inc (NASDAQ: MEDP ) reported Q2 revenue of $460.9 million, up 31.2%Y/Y, beating the consensus of $433.69 million, representing a backlog conversion rate of 18.7% .

Net new business awards were $574.8 million, up 27.6% Y/Y, which resulted in a net boo

You are viewing a robot-friendly page.Click hereto reload in standard format.